...
首页> 外文期刊>Cancer investigation >Prognostic predictors and long-term outcome of postoperative irradiation in thymoma: a study of 241 patients.
【24h】

Prognostic predictors and long-term outcome of postoperative irradiation in thymoma: a study of 241 patients.

机译:胸腺瘤术后放疗的预后预测因素和长期结果:241例患者的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to identify the prognostic predictors treated with postoperative irradiation in patients with thymoma. Two hundred forty-one patients with histologically confirmed thymoma were collected and retrospectively reviewed in this study. Fifty-four patients had stage I disease; 57, stage II; 120, stage III; 10, stage IV. One hundred sixty patients underwent total thymectomy; 63, partial resection; 18, debulking or biopsy. Patients were irradiated after surgery with median dose of 50 Gy by conventional fractionation. The overall survival rates at 5 and 10 years were 83.1% and 72.6%, respectively. The 10-year overall survival was 87% for stage I, 78.7% for stage II, 57.4% for stage III, and 24.3% for stage IV. The conclusions were drawn from this analysis. For stage I, the role of postoperative irradiation needed further investigation. For stage II-III, surgery and postoperative irradiation should be part of standard care. The favorable prognostic predictors were female, early stage, and surgical extirpation.
机译:这项研究的目的是确定胸腺瘤患者术后放射治疗的预后指标。收集了241例经组织学证实为胸腺瘤的患者,并进行了回顾性研究。五十四名患者患有I期疾病; 57,第二阶段;第三阶段120; 10,第四阶段一百六十例行全胸腺切除术; 63,局部切除; 18,减活或活检。手术后通过常规分级以中位数剂量50 Gy照射患者。 5年和10年的总生存率分别为83.1%和72.6%。 I期的10年总生存率为87%,II期为78.7%,III期为57.4%,IV期为24.3%。从这一分析得出结论。对于I期,术后放疗的作用需要进一步研究。对于II-III期,手术和术后放疗应作为标准护理的一部分。良好的预后预测指标是女性,早期和手术摘除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号